ReviewArchives of microbiology2025
The molecular mechanisms of quinolone resistance in Salmonella: a review.
Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reversing Antibiotic Resistance: Strategies From Adjuvants to Innovative Therapeutics.MicrobiologyOpen · 2026Review
- Asymptomatic Carriage and Antimicrobial Resistance ofMicroorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Salmonella is an important foodborne pathogen, and its quinolone resistance poses a considerable threat to public health. This review comprehensively analyzes various quinolone resistance mechanisms of Salmonella, including mutations in genes encoding drug targets, export of quinolones by efflux pump systems, decrease in Salmonella cell permeability, and the formation of special physiological states. The gyrA and parC are two important genes encoding the drug targets of quinolones, and their genetic mutations result in the drug targets being unable to be recognized by quinolones. Many efflux pumps, such as AcrAB, MdtABC, MdsABC, EmrAB, etc., transport quinolones out of Salmonella cells. A reduction in the expression of some porins decreases quinolone permeability, further aggravating drug resistance. In addition, special physiological states of Salmonella, such as a low metabolic state, biofilms, and quorum sensing, significantly increase quinolone resistance of Salmonella. The development of quinolone resistance in Salmonella is a complex process involving the synergistic effects of multiple mechanisms.
Indexed as
Identifiers
40828473What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.